Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Assessing the real-world safety of vutrisiran for transthyretin-mediated amyloidosis with polyneuropathy: Based on WHO-VigiAccess and FAERS databases
Saved in:
| Published in: | PLOS ONE |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Assessing the real-world safety of vutrisiran for transthyretin-mediated amyloidosis with polyneuropathy: Based on WHO-VigiAccess and FAERS databases
- Mining the FAERS database reveals new safety signals for 120 mg denosumab in oncology practice
- Colorectal carcinoma and chronic inflammatory demyelinating polyneuropathy: is there a possible ...
- Economic Burden of Overall and Advanced Light Chain Amyloidosis: Results from a Claims Linked Electronic Health Record Database Analysis
- Vigi4Eudra-score: Evaluation of the completeness of spontaneous adverse drug reaction reports in EudraVigilance
- Preserving Long-Term Access to Decommissioned Database Systems With Immortal Database Access (iDA)
- Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression